HEPTROMIC, a new approach to Hepatocellular Carcinoma
HEPTROMIC is the first research network funded by the European Commission devoted to the study of Hepatocellular Carcinoma (HCC). It is a 3-year translational...
News from November 2010
Spain is leading the fight against rare anemias in Europe
It is estimated that rare diseases -those whose frequency is under 5 cases / 10,000 people- affect about 6% of the European population. In the field of...